Effects of Omega-3 fatty acids supplementation on oxidative stress and MMP2/9 in patients with gastric cancer during chemotherapy

Journal of Animal and Veterinary Advances

Volumn 11, Issue 11, 2012, Pages 1858-1863

  Nemati, Ali ^a   Mahdavi, Reza ^b   Faizi Khankandi, Iraj ^c   Amani, Mojtaba ^c   Hazrati, Sadegh ^c   Baghi, Abbas Naghizadeh ^c   Mazani, Mohammad ^c   Amani, Firoz ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c School of Health   (Iran)

Author keywords

Ardabil; Gastric cancer; Iran; MMP2; MMP9; Oxidative stress

Indexed keywords

EID: 84864108121     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2012.1858.1863     Document Type: Article

References (39)

1. Ajani, J.A., V.M. Moiseyenko, S. Tjulandin, A. Majlis and M. Constenla et al. 2007. Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal adenocarcinoma: The V-325 sudy group. J. Clin. Oncol., 25: 3205-3209.
2. Ala-Aho, R. and V.M. Kahari, 2005. Collagenases in cancer. Biochimie, 87: 273-286.
3. Bakan, E., S. Taysi, M.F. Polat, S. Dalga, Z. Umudum, N. Bakan and M. Gumus, 2002. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn. J. Clin. Oncol., 32: 162-166.
4. Baracos, V.E., V.C. Mazurak andD.W.L. Ma, 2004. n-3 Polyunsaturated fatty acids throughout the cancer trajectory: Influence on disease incidence, progression, response to therapy and cancer-associated cachexia. Nut. Res. Rev., 17: 177-192.
5. Barber, M.D., K.C. Fearon, M.J. Tisdale, D.C. McMillan and J.A. Ross, 2001. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr. Cancer, 40: 110-124.
6. Bhattacharya, A., S. Ghosal and S. Bhattacharya, 2006. Effect of fish oil on offensive and defensive factors in gastric ulceration in rats. Prostaglandins leukotrienes Essent. Fatty Acids, 74: 109-116.
7. Bougnoux, P., E. Germain, V. Chajes, B. Hubert and C. Lhuillery et al., 1999. Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Br. J. Cancer, 79: 1765-1769.
8. Bramhall, S., M. Hallissey, J. Whiting, J. Scholefield and G. Tierney et al., 2002. Marimastat as maintenance therapy for patients with advanced gastric cancer: A randomised trial. Br. J. Cancer, 86: 1864-1870.
9. Cheeseman, K.H., G.W. Burton, K.U. Ingold and T.F. Slater, 1984. Lipid peroxidation and lipid antioxidants in normal and tumor cells. Toxicol. Pathol, 12: 235-239.
10. Conklin, K.A., 2002. Dietary polyunsaturated fatty acids: Impact on cancer chemotherapy and radiation. Altera Med. Rev., 7: 4-21.
11. Egeblad, M. and Z. Werb, 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2: 161-174.
12. Ferlay, J., H.R. Shin, F. Bray, D. Forman, C. Mathers and D.M. Parkin, 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127: 2893-2917.
13. Furlong, C.E., R. Richter, S. Seidel and A. Motulsky, 1988. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. Hum. Genet., 43: 230-238.
14. Giacosa, A. and M. Rondanelli, 2008. Fish oil and treatment of cancer cachexia. Genes Nutr., 3: 25-28.
15. Grigioni, W., A. Derrico, C. Fortunato, M. Fiorentino and A. Mancini et al., 1994. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod. Pathol., 7: 220-225.
16. Hansson, L.E., O. Nyken, R Beagstrom, A. Wolk, A. Lindgren, J. Baron and H.O. Adami, 1994. Nutrients and gastric cancer risk: A population based case control study in Sweden. Int. J. Cancer, 57: 638-644.
17. Hardman, W.E., 2004. (n-3) fatty acids and cancer therapy. J. Nutr., 134: 3427-3430.
18. Honda, M., M. Mori, H. Ueo, K. Sugimachi and T. Akiyoshi., 1996. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut, 39: 444-448.
19. Kapoor, S., 2009. Immunomodulatory properties of omega-3 fatty acids: A possible explanation for their systemic, anti-carcinogenic effects. J. Leukocyte Biol, 85: 2-3.
20. Kekec, Y., S. Paydas, A. Tuli, S. Zorludemir, G. Sakman and G. Seydaoglu, 2009. Antioxidant enzyme levels in cases with gastrointesinal cancer. Eur. J. Int. Med., 20: 403-406.
21. Malekzadeh, R., M.H. Derakhshan and Z. Malekzadeh, 2009. Gastric cancer in Iran: Epidemiology and risk factors. Arch. Iran. Med., 12: 576-583.
22. McCabe, A., J. Wallace, W. Gilmore, J. Strain and H. McGlynn, 1999. The effect of eicosapentanoic acid on matrix metalloproteinase gene expression. Lipids, 34: 217-218.
23. Mitjavila, M.T., M.C. Rodriguez, M.P. Saiz, S. Lloret and J.J. Moreno, 1996. Effect of degree of unsaturation in dietary fatty acids on arachidonic acid mobilization by peritoneal macrophages. Lipids, 31: 661-666.
24. Mojtahedi, A., R. Salehi, F. Navabakbar, H. Tamizifar, H. tavakoli and V. Duronio, 2007. Evaluation of apoptosis induction using PARP cleavage on gastric adenocarcinoma and fibroblast cell lines by different strains of Helicobacter pylori. Pak. J. Biol. Sci., 10: 4097-4102.
25. Moses, A.G.W., C. Slater, T. Preston, M. Barber and K.C.H. Fearon, 2004. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br. J. Cancer, 90: 996-1002.
26. Munoz, N, M. Plummer, J. Vivas, V. Moreno, S. De Sanjose, G. Lopez and W. Oliver, 2001. A case control study of gastric cancer in Venezuela. Int. J. Cancer, 93: 417-423.
27. Nagase, H. and J.F.J. Woessner, 1999. Matrix metalloproteinases. J. Biol. Chem., 274: 21491-21494.
28. Nomura, A.M.Y., J.H. Hankin, L.N. Kolonel, L.R Wilkens, M.T. Goodman and G.N. Stemmermann, 2003. Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control, 14: 547-558.
29. Oberley, L.W., M.L. McCormick, E. Sierra-Rivera and D.K.S. Clair, 1989. Manganese superoxide dismutase in normal and transformed human embryonic lung fibroblasts. Free Radical Biol. Med., 6: 379-384.
30. Rahimi, H.R., M. Arastoo and M. Shiri, 2011. Punica granatum is more effective to prevent gastric disorders induced by Helicobacter pylori or any other stimulator in humans. Asian J. Plant Sci., 10: 380-382.
31. Sadjadi, A., R. Malekzadeh, M.H. Derakhshan, A. Sepehr and M. Nouraie et at, 2003. Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int. J. Cancer, 107: 113-118.
32. Sier, C, F. Kubben, S. Ganesh, M. Heerding and G. Griffioen et at, 1996. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br. J. Cancer, 74: 413-417.
33. Stamenkovic, I., 2000. Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol., 10: 415-433.
34. Suzuki, I., M. Iigo, C. Ishikawa, T. Kuhara and M. Asamoto et al, 1997. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon carcinoma 26 cells are associated with reduced matrix metalloproteinase 2 and 9 activities. Int. J. Cancer, 73: 607-612.
35. Tisdale, M. and M. Mahmoud, 1983. Activities of free radical metabolizing enzymes in tumours. Br. J. Cancer, 47: 809-812.
36. Tsuzuki, T., A. Shibata, Y. Kawakami, K. Nakagawa and T. Miyazawa, 2007. Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cells. J. Nutr., 137: 641-646.
37. Uemura, N., S. Okamoto, S. Yamamoto, N. Matsumura and S. Yamaguchi et al., 2001. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med., 345: 784-789.
38. Yu, J.H., S.G. Kang, U.Y. Jung, C.H. JunandH. Kim, 2009. Effects of omega 3 fatty acids on apoptosis of human gastric epithelial cells exposed to silica immobilized glucose oxidase. Ann. N. Y. Acad. Sci., 1171: 359-364.
39. Zucker, S., C. Jianand W.T. Chen, 2000. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene, 19: 6642-6650.